Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

SPDR SP PHARMACEUTICALS ETF: (AMEX : XPH)

(U.S : AMEX) As of Jul 25, 2014 03:59 PM ET

 Add to portfolio

$98.86 USD

-0.89 (-0.89%)

Volume: 57,870

Zacks ETF Rank: 2 - Buy [?]   2      

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 99.75
Open 99.50
Bid 96.00
Ask 104.10
Day Low-High 98.66-99.51
52wk Low-High 73.06-106.76
Volume 57,870
NAV (month end) 103.71
Premium (+)/Discount (-) (month end)-3.96

Zacks Premium Research for XPH

Zacks ETF Rank [?] Buy 2
ETF Risk [?] Med
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $0.54 (0.54%)
Issuer STATE STREET GLOBAL ADVISORS

Benchmark for XPH

SP PHARMACEUTICALS SELECT INDUSTRY INDEX

The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the US common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Pharmaceuticals Index is a modified equal weight index.

Fund Summary for XPH

SPDR SP PHARMACEUTICALS ETF

The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible, before expenses, the total return performance of the S&P Pharmaceuticals Select Industry Index.